Note: This document contains side effect information about lutropin alfa. Some dosage forms listed on this page may not apply to the brand name Luveris.
Applies to lutropin alfa: subcutaneous powder for injection.
General
The most commonly reported adverse events reported have included headache, pelvic and abdominal pain, nausea, injection site reactions, and mild or moderate ovarian hyperstimulation syndrome (OHSS).[Ref]
Endocrine
Common (1% to 10%): Ovarian hyper-stimulation syndrome (OHSS), ovarian cyst, breast pain, pelvic pain
Frequency not reported: Abortion, breast enlargement, endometrial disorder, genital edema, hemorrhage in pregnancy, leucorrhoea, pelvic pain, pelvic congestion, ectopic pregnancy, premenstrual tension, uterine disorder not otherwise specified, uterine spasm, vaginal candidiasis, vaginal hemorrhage, vaginitis
Local
Common (1% to 10%): Injection site reactions[Ref]
During clinical trials, 7.4% of patients reported mild and moderate injection site reactions consisting of bruising, pain, redness, itching, or swelling; there were no reports of severe injection site reactions[Ref]
Genitourinary
Common (1% to 10%): Dysmenorrhea
Frequency not reported: Dysuria, micturition frequency change[Ref]
Gastrointestinal
Common (1% to 10%): Abdominal pain, abdominal discomfort, nausea, vomiting, diarrhea, flatulence, constipation,
Frequency not reported: Tooth caries[Ref]
Cardiovascular
Very rare (less than 0.01%): Thromboembolism
Frequency not reported: Vasodilation[Ref]
Musculoskeletal
Frequency not reported: Asthenia, back pain, leg cramps, leg pain, skeletal pain[Ref]
Nervous system
Common (1% to 10%): Headache
Frequency not reported: Hyperkinesia, dizziness[Ref]
Respiratory
Frequency not reported: Cough, dyspnea, pharyngitis, rhinitis[Ref]
Hypersensitivity
Mild to severe hypersensitivity reactions including anaphylactic reactions and shock have been reported.
Very rare (less than 0.01%): Hypersensitivity reactions
Immunologic
Frequency not reported: Herpes simplex, infection, influenza-like symptoms, Klebsiella
Ocular
Frequency not reported: Conjunctivitis
Psychiatric
Frequency not reported: Anxiety, depression, insomnia, nervousness, somnolence
Oncologic
There have been reports of ovarian and other reproductive system neoplasms, both benign and malignant, in women who have undergone multiple treatment regimens for infertility. It has not been established whether or not treatment with gonadotropins increases the risk of these tumors in infertile women.
Frequency not reported: Neoplasms
Other
Frequency not reported: Fever, not otherwise specified; fever
Dermatologic
Frequency not reported: Acne, nail disorder, rash dry skin